Courtesy of Purdue University/Rebecca McElhoe
Author By Construction Dive Staff
Published Feb. 10, 2021
Dive Brief:
Purdue University engineers have developed sensors that could safely speed up a construction timeline by determining concrete strength directly on site in real time.
Typically, concrete mix designs require testing before implementation in a construction project. Once those mixes have been vetted for use, the mix design cannot be altered without additional offsite testing. The new technology would remove the need for extensive offsite testing by allowing construction contractors to verify the concrete’s maturity on site.
“Our sensors could help make better data-driven decisions to determine the construction schedule and improve the quality of concrete construction,” said Luna Lu, Purdue’s American Concrete Pavement Assoc
Innovation is fluid, and the art of tapping into the right resources and support at the right time is crucial, particularly during a pandemic. Devin Hubbard, teaching associate professor in the UNC/NC State Joint Department of Biomedical Engineering and lead design engineer at the North Carolina Translational and Clinical Sciences Institute, has perfected the art of using resources offered by UNC-Chapel Hill’s campus innovation network to find quick answers to pressing problems.
In response to the increased need for personal protective equipment during the COVID-19 pandemic, Hubbard and his team launched Aerem Innovations, a technology company designing solutions for health care and commercial applications. The company is producing the AerFrame, a mask frame device designed to improve the comfort and effectiveness of existing face masks.
Pig stem cells offer a new way to grow human organs for transplantation
In a new paper published in
Stem Cell Reports, Bhanu Telugu and co-inventor Chi-Hun Park of the University of Maryland (UMD) Department of Animal and Avian Sciences show for the first time that newly established stem cells from pigs, when injected into embryos, contributed to the development of only the organ of interest (the embryonic gut and liver), laying the groundwork for stem cell therapeutics and organ transplantation.
Telugu s start-up company, Renovate Biosciences Inc. (RBI), was founded with the goal of leveraging the potential of stem cells to treat terminal diseases that would otherwise require organ transplants, either by avoiding the need for transplants altogether or creating a new pipeline for growing transplantable human organs.
Credit: Edwin Remsberg, UMD
In a new paper published in
Stem Cell Reports, Bhanu Telugu and co-inventor Chi-Hun Park of the University of Maryland (UMD) Department of Animal and Avian Sciences show for the first time that newly established stem cells from pigs, when injected into embryos, contributed to the development of only the organ of interest (the embryonic gut and liver), laying the groundwork for stem cell therapeutics and organ transplantation. Telugu s start-up company, Renovate Biosciences Inc. (RBI), was founded with the goal of leveraging the potential of stem cells to treat terminal diseases that would otherwise require organ transplants, either by avoiding the need for transplants altogether or creating a new pipeline for growing transplantable human organs. With the number of people who suffer from organ failures and the 20 deaths per day in the U.S. alone purely from a lack of available organs for transplant, finding a new way to provide organs and therapeutic opt